Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients
Cancer Medicine · 2023
DOI: 10.1002/cam4.6479 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Medicine, 2023. Verfasst von İrem Kar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Ankara University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Deep Learning, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The curative treatment for Stage I non‐small cell lung cancer (NSCLC) is surgical resection. Even for Stage I patients, the probability of recurrence after curative treatment is around 20%.
Methods
In this retrospective study, we included 268 operated Stage I NSCLC patients between January 2008 and June 2018 to analyze the prognostic factors (pathological stage, histological type, number of sampled mediastinal lymph node stations, type of resection, SUVmax of the lesion) that may affect relapse with three different methods, Cox proportional hazard (CoxPH), random survival forest (RSF), DeepSurv, and to compare the performance of these methods with Harrell's C‐index. The dataset was randomly split into two sets, training and test sets.
Results
In the training set, DeepSurv showed the best performance among the three models, the C‐index of the training set was 0.832, followed by RSF (0.675) and CoxPH (0.672). In the test set, RSF showed the best performance among the three models, followed by DeepSurv with 0.677 and CoxPH methods with 0.625.
Conclusion
In conclusion, machine‐learning techniques can be useful in predicting recurrence for lung cancer and guide clinicians both in choosing the adjuvant treatment options and best follow‐up programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Ankara University School of Medicine, Ankara, Turkey.
- Department of Thoracic Surgery, Ankara University School of Medicine, Ankara, Turkey.
- Genomics Team, Microsoft Research & AI, Redmond, Washington, USA.
ORCID-Profile: İrem Kar, Atilla Halil Elhan
Zitieren
APA
Kar, İ., Kocaman, G., İbrahimov, F., Enön, S., Coşgun, E., & Elhan, A. H. (2023). Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients. Cancer Medicine. https://doi.org/10.1002/cam4.6479
Vancouver
Kar İ, Kocaman G, İbrahimov F, Enön S, Coşgun E, Elhan AH. Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients. Cancer Medicine. 2023. doi:10.1002/cam4.6479
BibTeX
@article{Kar2023,
author = {Kar, İrem and Kocaman, Gökhan and İbrahimov, Farrukh and Enön, Serkan and Coşgun, Erdal and Elhan, Atilla Halil},
title = {Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6479}
}
EUVIMED